{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:06:41Z","timestamp":1761512801416},"reference-count":59,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T00:00:00Z","timestamp":1268870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p><jats:italic>Please cite this paper as:<\/jats:italic> Cotton S, Sharp L, Little J, Cruickshank M, Seth R, Smart L, Duncan I, Harrild K, Neal K, Waugh N, The TOMBOLA (Trial Of Management of Borderline and Other Low\u2010grade Abnormal smears) Group. The role of human papillomavirus testing in the management of women with low\u2010grade abnormalities: multicentre randomised controlled trial. BJOG 2010; DOI: 10.1111\/j.1471\u20100528.2010.02519.x.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To assess the value of a single human papillomavirus (HPV) test in making decisions on management of women with cervical cytology showing borderline nuclear abnormality (BNA) or mild dyskaryosis. In particular, to determine whether information on high\u2010risk (hr) HPV status would be valuable in the choice between (1) cytological surveillance versus immediate referral to colposcopy, and (2) at colposcopy, between biopsy and recall versus immediate large loop excision of the transformation zone (LLETZ).<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> Multicentre individually randomised controlled trial, nested within the NHS Cervical Screening Programmes, investigating the value of HPV testing by testing for interactions between HPV status and (1) cytological surveillance versus colposcopy, and (2) biopsy and recall versus immediate LLETZ.<\/jats:p><jats:p><jats:bold>Setting\u2002<\/jats:bold> Grampian, Tayside and Nottingham.<\/jats:p><jats:p><jats:bold>Population\u2002<\/jats:bold> Women (<jats:italic>n<\/jats:italic>\u2003=\u20034439), aged 20\u201359\u2003years, with a cytology test showing borderline nuclear abnormalities or mild dyskaryosis during October 1999 to October 2002.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> High\u2010risk HPV status was determined at recruitment using the polymerase chain reaction assay with the GP5+\/6+ general primer system. The results of this HPV testing were not disclosed to either the participating women or to those involved in their management. Women were randomised to either (1) 6\u2010monthly cytological screening in primary care or (2) referral for colposcopy. Human papillomavirus status was used to stratify both randomisations. All women were followed for 3\u2003years, concluding with an invitation to an exit appointment at which colposcopic examination was undertaken. In addition, in women who were randomised to initial colposcopy and underwent colposcopy, the association between hrHPV status and presence of cervical intraepithelial neoplasia (CIN) grade 2 or more severe disease (henceforth CIN2 or worse) was examined.<\/jats:p><jats:p><jats:bold>Main outcome measures\u2002<\/jats:bold> Sensitivity, specificity, positive and negative predictive values of the HPV test for predicting CIN2 or worse and the implications for the choice of management between cytological surveillance and immediate referral for colposcopy.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> There were no significant interactions between management and HPV status. Hence, in women with mild dyskaryosis or BNA who are HPV positive, there is no advantage of (1) immediate colposcopy over cytological surveillance (<jats:italic>P<\/jats:italic>\u2003=\u20030.76) or (2) immediate LLETZ over biopsy and recall (<jats:italic>P<\/jats:italic>\u2003=\u20030.27). The sensitivity of HPV testing for detection of CIN2 or worse was 75.2% (95%\u2003CI 68.8\u201381.0%) among women with mild dyskaryosis and 69.9% (95%\u2003CI 61.7\u201377.3%) among those with BNA. Specificity was higher in those with BNA (71.3%; 95%\u2003CI 68.5\u201374.1%) than in those with mild dyskaryosis (46.9%; 95%\u2003CI 42.2\u201351.6%). Sensitivity decreased with increasing age whereas specificity increased. The negative predictive value was high, particularly among women with BNA (94.5%; 95%\u2003CI 92.9\u201396.0%). Across all ages, 22% of women who had CIN2 or worse were HPV negative. Conversely, 40% of those who were HPV positive did not have CIN. HPV was a much more reliable predictor in women aged over 40\u2003years.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> We conclude that in younger women with low\u2010grade cytological abnormalities, a single HPV test would not be useful in determining who should be referred for colposcopy or the most effective management at colposcopy. In women over 40, a negative HPV test could be used to rule out further investigation.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2010.02519.x","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T14:56:30Z","timestamp":1271688990000},"page":"645-659","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The role of human papillomavirus testing in the management of women with low\u2010grade abnormalities: multicentre randomised controlled trial"],"prefix":"10.1111","volume":"117","author":[{"given":"S","family":"Cotton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Smart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Harrild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Neal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The TOMBOLA (Trial Of Management of Borderline and Other Low\u2010grade Abnormal smears) Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,8]]},"reference":[{"volume-title":"Cervical Cytology Workload Statistics (Quarter ending 30 September 2003)","year":"2004","author":"NHS Scotland, Information & Statistics Division","key":"e_1_2_12_2_2"},{"volume-title":"Annual Review 2002: Building on Experience","year":"2002","author":"NHS Cervical Screening Programme","key":"e_1_2_12_3_2"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7395.901"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.lgt.0000192695.93172.75"},{"volume-title":"Cervix Cancer Screening","year":"2005","author":"IARC Working Group","key":"e_1_2_12_6_2"},{"volume-title":"The Aetiology of Cervical Cancer","year":"2005","author":"Bosch FX","key":"e_1_2_12_7_2"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61416-0"},{"key":"e_1_2_12_9_2","first-page":"1","article-title":"A systematic review of the role of human papillomavirus testing within a cervical screening programme","author":"Cuzick J","year":"1999","journal-title":"Health Technol Assess"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20839"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21513"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802123380703"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04956-4"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1689"},{"key":"e_1_2_12_15_2","first-page":"347","volume-title":"Sexually Transmitted Diseases","author":"Koutsky L","year":"1999"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38701.440961.7C"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38698.458866.7C"},{"key":"e_1_2_12_19_2","unstructured":"NHS Cancer Screening Programmes.HPV Sentinel Sites Implementation Project.2008. [http:\/\/www.cancerscreening.nhs.uk\/cervical\/hpv.html#sentinel\u2010sites]. Accessed 29 January 2008."},{"key":"e_1_2_12_20_2","first-page":"1","volume-title":"Triage of women with Atypical or Low\u2010grade Cytological Abnormalities of the Cervix by HPV Testing: Systematic Review and Meta\u2010analysis","author":"Arbyn M","year":"2002"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.07.033"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.5.397"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(03)00413-7"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(03)00418-6"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj009"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603210"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603245"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603822"},{"key":"e_1_2_12_29_2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.5858\/2003-127-1169-AHPTIT","article-title":"Adjunctive human papillomavirus testing in the 2\u2010year follow\u2010up of women with low\u2010grade cervical cytologic abnormalities","volume":"127","author":"Lytwyn A","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh063"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7291.893"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7291.878"},{"key":"e_1_2_12_33_2","first-page":"701","article-title":"Comparison of human papillomavirus DNA testing and repeat papanicolaou test in women with low\u2010grade cervical cytologic abnormalities: a randomized trial","volume":"163","author":"Lytwyn A","year":"2000","journal-title":"Can Med Assoc J"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14955-0"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(01)00457-2"},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6150"},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089160509100216"},{"key":"e_1_2_12_38_2","first-page":"239","article-title":"Efficiency of three surgical procedures in eliminating high\u2010risk human papillomavirus infection in women with precancerous cervical lesions","volume":"27","author":"Jancar N","year":"2006","journal-title":"Eur J Gynaecol Oncol"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2546"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2548"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2006.04.001"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2549"},{"key":"e_1_2_12_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.3.791-795.1997"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1647"},{"volume-title":"Cancer Mortality for Selected Sites in 24 Countries (1950\u20131957)","year":"1960","author":"Segi M","key":"e_1_2_12_45_2"},{"volume-title":"Liquid Based Cytology (LBC): The Conversion to LBC is Now Complete","year":"2009","author":"NHS Cervical Screening Programme","key":"e_1_2_12_46_2"},{"key":"e_1_2_12_47_2","unstructured":"MossSM GrayA MarteauT LegoodR HenstockE MaissiEEvaluation of HPV\/LBC Cervical Screening Pilot Studies. Report to the Department of Health (revised October 2004).2004:1\u2013307. [http:\/\/www.cancerscreening.nhs.uk\/cervical\/evaluation\u2010hpv\u20102006feb.pdf]. Accessed 1 December 2009."},{"key":"e_1_2_12_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00342.x"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-6349.2005.00702.x"},{"key":"e_1_2_12_50_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2003.00155.x"},{"key":"e_1_2_12_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(98)00245-2"},{"key":"e_1_2_12_52_2","first-page":"47","article-title":"Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type","volume":"1","author":"Jeronimo J","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_12_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073204"},{"key":"e_1_2_12_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh037"},{"key":"e_1_2_12_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21713"},{"key":"e_1_2_12_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.12.003"},{"key":"e_1_2_12_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20736"},{"key":"e_1_2_12_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00361.x"},{"key":"e_1_2_12_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2004.11.024"},{"key":"e_1_2_12_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68181-6"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2010.02519.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2010.02519.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T14:03:11Z","timestamp":1698760991000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2010.02519.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,8]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1471-0528.2010.02519.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02519.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"type":"print","value":"1470-0328"},{"type":"electronic","value":"1471-0528"}],"subject":[],"published":{"date-parts":[[2010,4,8]]},"assertion":[{"value":"2010-04-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}